Optimized inhaler mouthpiece design allows for more effective drug deliveryOctober 22, 2009Research to be presented in November at the 2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition Researchers have developed an optimized mouthpiece design to aid efficient drug delivery to the lungs by reducing the amount of medication wasted as it passes through the mouthpiece of an aerosol inhaler. With current inhaler designs, only approximately 10 to 20 percent of asthma medications are delivered to the lungs. And, because the lungs provide a direct and effective route of entry for medications into the bloodstream, an optimized mouthpiece design will reduce medication waste and may provide reproducible delivery of future inhaled medications. "Through a process of computational and experimental analysis and design for a new inhaler, we were able to optimize a prototype mouthpiece that allowed for more medication to pass through the mouthpiece and be available to reach the lungs," said Michael Hindle, Ph.D., research associate professor at Virginia Commonwealth University (VCU) School of Pharmacy and presenter at the 2009 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. "By optimizing the design, it will help ensure delivery efficiency so less medication will be wasted and more will be effectively delivered to the lungs for relief from symptoms." Dr. Hindle adds that this rational computational inhaler analysis and design approach, which was developed with Worth Longest, Ph.D. from the School of Engineering at VCU, may be applicable for other inhalers and medications that require reproducible delivery. "Insulin is an example of a drug that requires a reproducible delivery strategy that can be administered painlessly and as effectively through aerosol inhalers." Further research at this year's AAPS Annual Meeting and Exposition will address computational and experimental design methods to improve inhaler performance and how they affect the future of aerosol drug delivery. American Association of Pharmaceutical Scientists |
|||||||||||||||||||||
| Related Inhaler Current Events and Inhaler News Articles New vaccine delivery may be more effective against measles Worldwide, there are estimated to be 10 million cases of measles and 197,000 deaths from the disease each year. While vaccines exist to protect children against measles, the vaccines are often difficult to store, costly to transport and may be prone to contamination when shipped to developing countries. Needle-free, inhalant powder measles vaccine could save thousands of lives The first dry powder inhalable vaccine for measles is moving toward clinical trials next year in India, where the disease still sickens millions of infants and children and kills almost 200,000 annually, according to a report presented here today at the 238th National Meeting of the American Chemical Society (ACS). Discovery may lead to powerful new therapy for asthma University of Texas Medical Branch at Galveston researchers have found that a single enzyme is apparently critical to most allergen-provoked asthma attacks - and that activity of the enzyme, known as aldose reductase, can be significantly reduced by compounds that have already undergone clinical trials as treatments for complications of diabetes. Heavy breathing -- an obscure link in asthma and obesity There is a strong link between obesity and asthma and as the prevalence of both conditions has been increasing steadily, epidemiologists have speculated that there is an underlying condition that connects the two. Pharmacists as educators can improve asthma outcomes New research has shown that up to 90 per cent of people on asthma medications are using their inhalers incorrectly leading to poor asthma control, increased hospital visits and increased cost of treatment. First do no harm? UH prof taking opposite approach to treat asthma One month of tough breathing may help asthma sufferers breathe easier in the long run, according to research from one University of Houston professor. UNC, Harvard develop inhaled TB vaccine A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide. Diesel exhaust fumes affect people with asthma, finds study on London's Oxford Street Diesel exhaust fumes on polluted streets have a measurable effect on people with asthma, according to the first study looking at exhausts and asthma in a real-life setting, published on 6 December in the New England Journal of Medicine. Clinical trials nebulized formoterol fumarate: Long-term and cardiovascular safety COPD Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), supporting the use of Perforomist (formoterol fumarate) Inhalation Solution as a safe and effective maintenance treatment for COPD patients. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials By better understanding how antimicrobials bind and thereby get inactivated in the mucus of air passages, researchers at the University of Illinois may have found a way to help cystic fibrosis patients fight off deadly infections. More Inhaler Current Events and Inhaler News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||